Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease | Cell Type | Therapeutic or Technology | Institution | Stage |
Project Objective![]() |
Details |
---|---|---|---|---|---|---|
Blood Disorders | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Vision Loss | iPS Cell | Small molecule therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Type 1 diabetes | Embryonic Stem Cell | Gene-modified, donor cell therapy | Lundquist Institute |
![]() |
Development Candidate, Proof of Concept | |
Liver Disease | iPS Cell | Gene-modified, donor cell therapy | CHLA |
![]() |
Development Candidate, Proof of Concept | |
Colon Cancer | Cancer Stem Cell | Small molecule therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Inflammatory bowel disease | Adult Stem Cell | Donor cell therapy | Vitabolus, Inc. |
![]() |
Development Candidate, Proof of Concept | |
Autism | iPS Cell | Small molecule therapy | Scripps |
![]() |
Development Candidate, Proof of Concept | |
COVID-19, Respiratory Disorders |
iPS Cell | Gene-modified, donor cell therapy | USC |
![]() |
Development Candidate, Proof of Concept | |
Neurological Disorders | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Development Candidate, Proof of Concept | |
Bladder or Urinary Tract Disorder, Solid Tumors |
Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
COVID-19, Respiratory Disorders |
iPS Cell | Small molecule therapy | Sanford-Burnham |
![]() |
Development Candidate, Proof of Concept | |
Amyotrophic Lateral Sclerosis | iPS Cell | Nucleic acid based therapy | USC |
![]() |
Development Candidate, Proof of Concept | |
COVID-19, Respiratory Disorders |
iPS Cell | Small molecule therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Traumatic Brain Injury | iPS Cell | Donor cell therapy | UC Irvine |
![]() |
Development Candidate, Research Insights | |
Hearing Loss | Adult Stem Cell | Protein/peptide therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
COVID-19, Respiratory Disorders |
Adult Stem Cell | Model system development | UCLA |
![]() |
Development Candidate, Proof of Concept, Tool/Resources/Bottleneck | |
Stroke | iPS Cell | Donor cell therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
COVID-19, Respiratory Disorders |
Adult Stem Cell | Biologic | UCSD |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | iPS Cell | Small molecule therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | iPS Cell | Small molecule therapy | Scripps |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | Adult Stem Cell | Gene-modified, donor cell therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | iPS Cell | Small molecule therapy | USC |
![]() |
Development Candidate, Proof of Concept | |
Traumatic Brain Injury | Embryonic Stem Cell | Exosomes based therapy | UC Irvine |
![]() |
Development Candidate, Proof of Concept, Research Insights | |
Spinal Cord Injury | Embryonic Stem Cell | Therapeutic Approach | UCSD |
![]() |
Development Candidate, Research Insights | |
Brain Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Ovarian Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Development Candidate, Proof of Concept | |
Thymic Disorder, 22q11 Deletion/DiGeorge |
Embryonic Stem Cell, iPS Cell |
Donor cell therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | Adult Stem Cell | Small molecule therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Hemophilia A | Adult Stem Cell | Gene modification | COH |
![]() |
Development Candidate, Proof of Concept | |
Heart Disease, Danon Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | Adult Stem Cell | Vaccine | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Stroke | Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
IND | |
HIV/AIDS | Personalized cell therapy | COH |
![]() |
IND | ||
Parkinson's Disease | Adult Stem Cell | Gene-modified, donor cell therapy | UCSF |
![]() |
IND | |
Brain Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
IND | |
IPEX Syndrome, Immune Disease |
Vital Research Opportunity | Gene Therapy, cell free | Stanford |
![]() |
IND | |
Spina Bifida | Adult Stem Cell | Donor cell therapy | UC Davis |
![]() |
IND | |
Huntington's Disease | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
IND | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
IND | |
Ovarian Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | COH |
![]() |
Pre-IND/IDE or Equivalent | |
Multiple Myeloma | Adult Stem Cell | Personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Epilepsy | Embryonic Stem Cell | Donor cell therapy | Neurona Therapeutics |
![]() |
Pre-IND/IDE or Equivalent | |
COVID-19 | Adult Stem Cell | Small molecule therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Cancer | Cancer Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Pre-IND/IDE or Equivalent | |
Bladder or Urinary Tract Disorder, Incontinence |
iPS Cell | Personalized cell therapy | Stanford |
![]() |
Pre-IND/IDE or Equivalent | |
Age-related macular degeneration | Embryonic Stem Cell | Biologic | USC |
![]() |
Pre-IND/IDE or Equivalent | |
Retinitis Pigmentosa | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
Traumatic Brain Injury | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent |